Muscle Cell News 2.33 October 2, 2017 | |
| |
TOP STORYScientists showed that β-catenin loss of function in cardiac fibroblasts after trans-aortic constriction significantly preserves cardiac function, and reduces interstitial fibrosis but does not alter the numbers of activated or differentiated cardiac fibroblasts in vivo. [Nat Commun] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)CARDIAC MUSCLE CELLSResearchers performed transcriptome analyses of beating cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) and induced cardiomyocytes (iCMs) generated from cardiac fibroblasts of the same origin. Although both iPSC-CMs and iCMs established CM-like molecular features globally, iPSC-CMs exhibited a relatively hyperdynamic epigenetic status, whereas iCMs exhibited a maturation status that more closely resembled that of adult CMs. [Cell Rep] Full Article | Press Release | Graphical Abstract Scientists generated induced pluripotent stem cells (iPSCs) from a patient with dilated cardiomyopathy (DCM) caused by a missense mutation S635A in RNA-binding motif protein 20 (RBM20) and investigated the functionality and cell biology of cardiomyocytes derived from patient-specific iPSCs (RBM20-iPSCs). [J Mol Cell Cardiol] Full Article To define the set of proteins specifically or highly differentially secreted by cardiac progenitor cell (CPC), investigators compared human mesenchymal stem cells and dermal fibroblasts; the study defined a group of growth factors, cytokines and chemokines expressed at high to medium levels by CPC. [Sci Rep] Full Article SKELETAL MUSCLE CELLSThe authors investigated lipid profiles over 24 hours in human skeletal muscle in vivo and in primary human myotubes cultured in vitro. The percentage of oscillating lipid metabolites was comparable between muscle tissue and cultured myotubes, and temporal lipid profiles correlated with transcript profiles of genes implicated in their biosynthesis. [Proc Natl Acad Sci USA] Full Article Using the proximity-dependent biotin identification method, investigators found several centrosomal proteins, including Akap450, Pcm1, and Pericentrin, whose association with Nesprin-1α was increased in differentiated myotubes. They showed that Nesprin-1α recruits Akap450 to the nuclear envelope (NE) independently of kinesin and that Akap450, but not other centrosomal proteins, are required for microtubule nucleation from the NE. [Curr Biol] Abstract | Graphical Abstract Researchers investigated the effects of negative pressure wound therapy (NPWT) on muscle-derived stem cell (MDSC) osteoblastic differentiation and the related potential mechanism. The cell proliferation rate was substantially increased in NPWT-treated MDSCs in comparison with a static group for three days. [J Cell Mol Med] Full Article Scientists demonstrated that a delivery vehicle composed of gold nanoparticles conjugated to DNA and complexed with cationic endosomal disruptive polymers could deliver Cas9 ribonucleoprotein and donor DNA into a wide variety of cell types and efficiently correct the DNA mutation that causes Duchenne muscular dystrophy in mice via local injection, with minimal off-target DNA damage. [Nat Biomed Eng] Abstract SMOOTH MUSCLE CELLSResearchers investigated the mechanisms by which nicotine affects human bronchial smooth muscle cell (HBSMC) proliferation. They verified that activation of the PI3K/Akt signaling pathway plays a pivotal role in nicotine-enhanced proliferation and calcium influx in HBSMCs. [Cell Physiol Biochem] Full Article The authors investigated the correlation between altered proteins, especially those related to ROS, and smooth muscle cell (SMC) differentiation in sphingosylphosphorylcholine (SPC)-stimulated human mesenchymal stem cells (hMSCs). Treatment with SPC resulted in an increased expression of SMC markers, namely α-smooth muscle actin and calponin, and an increased production of ROS in hMSCs. [Proteomics] Abstract Scientists investigated the possible role of apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) in inorganic phosphate (Pi)-induced vascular smooth muscle cell (VSMC) calcification. They observed that Pi decreased endogenous APE1/Ref-1 expression and promoter activity in VSMCs, and that adenoviral overexpression of APE1/Ref-1 inhibited Pi-induced calcification in VSMCs and in an ex vivo organ culture of a rat aorta. [Int J Mol Sci] Full Article | |
| |
REVIEWSVascular Stem/Progenitor Cells: Functions and Signaling Pathways During the past two decades, considerable progress has been achieved in the understanding of the derivation, surface markers, and differentiation of vascular stem/progenitor cells. Yet, the mechanisms regulating their functions and maintenance under normal and pathological conditions, such as in eye diseases, remain to be further elucidated. [Cell Mol Life Sci] Abstract Visit our reviews page to see a complete list of reviews in the muscle cell research field. | |
| |
SCIENCE NEWSCatabasis Pharmaceuticals, Inc. announced that the company will present data from the Catabasis and Sarepta joint research collaboration in Duchenne muscular dystrophy in a poster presentation titled “Edasalonexent, an NF-kB inhibitor, enhances myotube formation in vitro, and increases exon-skipped sarcolemmal dystrophin in muscle of mdx mice”. [Press release from Catabasis Pharmaceuticals, Inc. discussing research to be presented at the 22nd International Congress of the World Muscle Society, Saint Malo] Press Release | |
| |
INDUSTRY NEWSUofL Receives $13.8 Million to Study Promising New Heart Failure Treatment The University of Louisville has received one of its largest grants for medical research in the school’s 219-year history, a $13.8 million award from the National Institutes of Health to study a promising new type of adult cardiac stem cell that has the potential to treat heart failure. [University of Louisville] Press Release BioCardia announced that the independent data safety monitoring board has completed the pre-specified interim analysis of safety outcomes for the first ten patients treated in the Phase III trial of its investigational CardiAMP cell therapy product. [BioCardia®, Inc.] Press Release Capricor Therapeutics, Inc. announced that the national principal investigator for its HOPE-2 Trial will be Craig M. McDonald, M.D., a distinguished thought leader in the clinical management of neuromuscular diseases, including muscular dystrophies, and the development of novel outcome measures for Duchenne muscular dystrophy clinical trials. [Capricor Therapeutics, Inc.] Press Release | |
| |
POLICY NEWSHow the Latest US Travel Ban Could Affect Science Trump announced permanent travel restrictions on citizens of Chad, Iran, Libya, North Korea, Somalia, Syria, Venezuela and Yemen. That list includes five Muslim-majority countries that were targeted in the White House’s first and second travel bans, which Trump signed in January and March. Those policies, which were designed as temporary measures, have been limited by a series of federal court rulings. [Nature News] Editorial Researchers Caught in Growing Rift over Catalan Independence Scientists in Catalonia are feeling the ripples of a severe crisis as the region’s bid for independence from Spain comes to a head. [ScienceInsider] Editorial French Government Proposes Big Science-Spending Boost French research funding is set for a heartening increase in the country’s first budget under President Emmanuel Macron, if draft 2018 plans are voted into law. [Nature News] Editorial After Upheaval, Russian Academy of Sciences Gets New Leader After months of uncertainty, the Russian Academy of Sciences finally has a new leader. Russian President Vladimir Putin approved physicist Alexander Sergeyev as the academy’s president for the next 5 years. Sergeyev has vowed to secure more money for Russian science and create a fund, through a new tax on fossil fuel company profits, for upgrading the country’s antiquated research infrastructure. [ScienceInsider] Editorial
| |
EVENTSNEW The 2018 World Stem Cell Summit (WSCS) Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Research Assistant – Duchenne Muscular Dystrophy (University of Oxford) NEW Assistant Professor – Musculoskeletal Biology (University of Alabama) Postdoctoral Associate – Skeletal Muscle Differentiation (University of Minnesota) Faculty Positions – Cardiovascular Biology (Oklahoma Medical Research Foundation) Researcher – Skeletal Tissue Engineering (KU Leuven) Postdoctoral Fellowship – Cardiology (Temple University) Scientist – Obesity, Metabolic & Muscle Diseases (Regeneron) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Muscle Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|